Parr McKnight Wealth Management Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Hold
2,121
– – 0.03% 206
2026
Q1
$296K Hold
2,121
– – 0.04% 196
2025
Q4
$260K Hold
2,121
– – 0.03% 217
2025
Q3
$235K Hold
2,121
– – 0.03% 220
2025
Q2
$235K Hold
2,121
– – 0.03% 214
2025
Q1
$238K Buy
+2,121
New +$219K 0.03% 215

Other funds holding GILD

Parr McKnight Wealth Management Group's GILD Position: Q2 2026 in Review

Parr McKnight Wealth Management Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,121 shares worth $268K. The position accounts for 0.03% of the portfolio, ranked #206.

Parr McKnight Wealth Management Group first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $296K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Parr McKnight Wealth Management Group held 2,121 shares of Gilead Sciences worth $268K as of Q2 2026.
  • Parr McKnight Wealth Management Group left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.03% of Parr McKnight Wealth Management Group's portfolio in Q2 2026, its #206 holding.
  • Parr McKnight Wealth Management Group first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Parr McKnight Wealth Management Group's Gilead Sciences position peaked at $296K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Parr McKnight Wealth Management Group's 13F filing for Q2 2026, filed 5 Aug 2026.